ATE525076T1 - Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel - Google Patents

Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel

Info

Publication number
ATE525076T1
ATE525076T1 AT03786529T AT03786529T ATE525076T1 AT E525076 T1 ATE525076 T1 AT E525076T1 AT 03786529 T AT03786529 T AT 03786529T AT 03786529 T AT03786529 T AT 03786529T AT E525076 T1 ATE525076 T1 AT E525076T1
Authority
AT
Austria
Prior art keywords
treatment
articular cartilage
prevention
damage
articular
Prior art date
Application number
AT03786529T
Other languages
English (en)
Inventor
Frank D Marcum
Original Assignee
Arthrodynamic Technologies Animal Health Division Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthrodynamic Technologies Animal Health Division Inc filed Critical Arthrodynamic Technologies Animal Health Division Inc
Application granted granted Critical
Publication of ATE525076T1 publication Critical patent/ATE525076T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03786529T 2002-10-16 2003-10-16 Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel ATE525076T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41900902P 2002-10-16 2002-10-16
US48786103P 2003-07-16 2003-07-16
PCT/US2003/032555 WO2004034980A2 (en) 2002-10-16 2003-10-16 Treatment for traumatic synovitis and damaged articular cartilage

Publications (1)

Publication Number Publication Date
ATE525076T1 true ATE525076T1 (de) 2011-10-15

Family

ID=32110208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03786529T ATE525076T1 (de) 2002-10-16 2003-10-16 Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel

Country Status (8)

Country Link
US (1) US6979679B2 (de)
EP (1) EP1560588B1 (de)
AT (1) ATE525076T1 (de)
AU (1) AU2003295347B2 (de)
ES (1) ES2374157T3 (de)
NZ (1) NZ540045A (de)
PT (1) PT1560588E (de)
WO (1) WO2004034980A2 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US8455458B2 (en) * 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
ATE525076T1 (de) * 2002-10-16 2011-10-15 Arthrodynamic Technologies Animal Health Division Inc Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel
US7485629B2 (en) * 2002-10-16 2009-02-03 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treatment of joint damage
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
WO2005032562A1 (en) * 2003-10-09 2005-04-14 Robert John Petrella Methods for treating acute and overuse sprain and strain using hyaluronic acid
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
US9492381B1 (en) * 2005-11-10 2016-11-15 Reyn Pharma, Llc Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis
US8598144B1 (en) * 2005-11-10 2013-12-03 Reyn Pharma, Llc Method of administering hyaluronan formulation for the amelioration of osteoarthritis
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20080103746A1 (en) 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
WO2007070617A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
EP1968614A2 (de) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Behandlung von arthritis und andere muskel-und knochen-erkrankungen mit vernetzter hyaluronsäure
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
US8153614B2 (en) 2006-12-05 2012-04-10 Glycoscience Laboratories, Inc. Treatment of osteoarthritis
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
FR2918376B1 (fr) 2007-07-04 2011-10-28 Mathieu Borge Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
EP2106798A1 (de) * 2008-04-02 2009-10-07 Nestec S.A. Sulfatiertes ungesättigtes Disaccharid-Chondroitinsulfat für Schutz und Reparatur von Bindegewebe
US9056121B1 (en) * 2008-06-30 2015-06-16 Reyn Pharma, Llc Method of administering hyaluronan formulation for the amelioration of osteophytes
US8163716B1 (en) 2008-06-30 2012-04-24 Smith James D Method of administering hyaluronan formulation for the amelioration of osteophytes
US8178511B1 (en) 2008-07-02 2012-05-15 Smith James D Method of administering hyaluronan formulation for the amelioration of osteopenia
WO2010011857A2 (en) * 2008-07-23 2010-01-28 The Johns Hopkins University Parenteral administration of a glucosamine
RU2468839C2 (ru) * 2010-11-24 2012-12-10 Максимильян Григорьевич Кравчик Способ лечения воспалительно-дегенеративных патологий суставов
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
US9238071B2 (en) * 2012-05-01 2016-01-19 Karen K. Brown Hyaluronic acid stabilizer
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
EP2886104A1 (de) 2013-12-11 2015-06-24 Patir, Suleyman Intraartikuläres Gel
US10076537B2 (en) 2014-05-02 2018-09-18 Arthrodynamic Holdings, Llc Glycosaminoglycan composition and method of use for kidney stone removal
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
WO2016156354A1 (en) * 2015-03-31 2016-10-06 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical composition comprising loxoprofen, glucosamine, chondroitin, hyaluronic acid for joint and cartilage disorders
TR201505225A1 (en) * 2015-04-29 2016-11-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A pharmaceutical composition comprising zaltoprofen for joint and cartilage disorders.
US10531957B2 (en) 2015-05-21 2020-01-14 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
EP3111941A1 (de) 2015-06-30 2017-01-04 Süleyman Patir Zusammensetzungen mit chondroitinsulfat zur prophylaxe oder behandlung von geschädigtem gelenkknorpel
CZ33324U1 (cs) 2019-09-06 2019-10-25 Contipro A.S. Hydrogel na bázi zesíťovaného hydroxyfenylového derivátu kyseliny hyaluronové
CN111214478B (zh) * 2020-02-24 2023-08-08 海南医学院 弗如糖苷在制备治疗和/或预防滑膜相关疾病的药物中的用途
WO2024080954A1 (en) * 2022-10-11 2024-04-18 Patir Sueleyman Intra-articular gel for tissue and cartilage regeneration

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792346C3 (de) 1968-08-22 1980-10-23 Rotta Research Laboratorium S.P.A., San Fruttuoso Di Monza, Mailand (Italien) Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
SE8501723L (sv) 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4808576A (en) 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US5587563A (en) 1993-06-04 1996-12-24 Dipti Kr. Datta Air handling structure for pan inlet and outlet
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
US6608041B2 (en) 2000-02-18 2003-08-19 Milton Hammerly Analgesics combined with naturally-occurring chondroprotective agents
ATE525076T1 (de) * 2002-10-16 2011-10-15 Arthrodynamic Technologies Animal Health Division Inc Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel

Also Published As

Publication number Publication date
NZ540045A (en) 2008-04-30
EP1560588A2 (de) 2005-08-10
WO2004034980A2 (en) 2004-04-29
ES2374157T3 (es) 2012-02-14
AU2003295347B2 (en) 2010-02-11
US20040092479A1 (en) 2004-05-13
AU2003295347A1 (en) 2004-05-04
WO2004034980A3 (en) 2004-10-07
EP1560588B1 (de) 2011-09-21
EP1560588A4 (de) 2008-06-25
US6979679B2 (en) 2005-12-27
PT1560588E (pt) 2012-01-06

Similar Documents

Publication Publication Date Title
ATE525076T1 (de) Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel
HK1106161A1 (en) Amide derivatives of hyaluronic acid in osteoarthrosis
DE60205564D1 (de) N-Adamantylalkyl Benzamide Derivativen als p2x7-rezeptor antagonisten
BR0214032A (pt) Método terapêutico para o tratamento de uma junta demonstrando degeneração de cartilagem articular, uso de uma solução aquosa estáve, viscosa e tamponada, método para reparar ou regenerar cartilagem em uma junta de mamìferos, e, uso de uma mistura de sulfato de condroitina e ácido hialurÈnico ou sais farmaceuticamente aceitáveis dos mesmos
ATE432715T1 (de) Iniezierbare hyaluronat-sulphatierte polysaccharid konjugate
BR9916930A (pt) Compostos heterocìclicos aromáticos comoagentes antiinflamatórios
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
RS20050490A (en) 3-(3,5-dioxo-4,5-dihydro-3h- (1,2,4)triazin-2yl)benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE187447T1 (de) 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel
DE60219653D1 (de) Pharmazeutische zusammensetzung mit chito-oligomeren
IL172773A0 (en) Formulations for the treatment of arhritis conditions
IT1301994B1 (it) Derivati dell'acido ialuronico.
TR200200381T2 (tr) Pirimidin-2,4,6-Trion Metalloproteinaz İnhibitorler.
CY1113194T1 (el) Συνθεση και αντιϊικη δραστικοτητα παραγωγων υποκατεστημενης αζαϊνδολοοξοοξικης πιπεραζινης
ATE361300T1 (de) Derivate von heteroarylnitrilverbindungen
BR0312967A (pt) Derivados de pirimidil sulfonamidas como moduladores de receptor de quimiocina
BRPI0516568A (pt) biomateriais consistindo em ácido hialurÈnico sulfatado e gelana, bem como composição farmacêutica e uso dos mesmos
PT1385492E (pt) Utilização de derivados de ácido hialurónico para a inibição de artrites inflamatórias
IT1318403B1 (it) Esteri polisaccaridici di n-derivati di acido glutammico.
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
US9598505B2 (en) Silyl-derivatives of polysaccharides
EA201170369A1 (ru) Карбоксиэтилированные полисульфаты циклодекстрина, подходящие для применения в качестве лекарственных средств
DE60126416D1 (de) Behandlung von arthritis und entsprechende zusammensetzungen
ATE315049T1 (de) Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties